Stock Forecast
As of Sat Feb 27 2021 00:00:03 GMT+0000 (Coordinated Universal Time) shares of ESPR Esperion Therapeutics -1.05 percentage change in price since the previous day's close. Around 704665 of 27943000 changed hand on the market. The Stock opened at 27.89 with high and low of 26.23 and 28.24 respectively. The price/earnings ratio is: - and earning per share is -5.22. The stock quoted a 52 week high and low of 23.9 and 56.85 respectively.
BOSTON (AI Forecast Terminal) Sat, Feb 27, '21 AI Forecast today took the forecast actions: In the context of stock price realization of ESPR Esperion Therapeutics is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+30) for ESPR Esperion Therapeutics as below:
ESPR Esperion Therapeutics Credit Rating Overview
We rerate ESPR Esperion Therapeutics because market risk charges capture the risk of loss on trading portfolio at a one-year horizon and a 99.9% confidence level. We use econometric methods for period (n+30) simulate with Parabolic SAR (PSAR) Factor. Reference code is: 4225. Beta DRL value REG 12 Rational Demand Factor LD 5988.368399999999. We believe that when a company is viewed as being on the cusp between two liquidity descriptors and has higher-than-average cash plus inventory/unadjusted debt compared with similarly constituted peers, that helps support the better liquidity assessment. However, in the case of a nonresidential developer, given that its inventory is typically less liquid (and the greater potential for inventory to suffer value erosion in a downturn), we do not consider this measure as pertinent. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.
Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for ESPR Esperion Therapeutics as below:
Frequently Asked Questions
Q: What is ESPR Esperion Therapeutics stock symbol?A: ESPR Esperion Therapeutics stock referred as NASDAQ:ESPR
Q: What is ESPR Esperion Therapeutics stock price?
A: On share of ESPR Esperion Therapeutics stock can currently be purchased for approximately 27.39
Q: Do analysts recommend investors buy shares of ESPR Esperion Therapeutics ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for ESPR Esperion Therapeutics at daily forecast section
Q: What is the earning per share of ESPR Esperion Therapeutics ?
A: The earning per share of ESPR Esperion Therapeutics is -5.22
Q: What is the market capitalization of ESPR Esperion Therapeutics ?
A: The market capitalization of ESPR Esperion Therapeutics is 765348070
